Long-acting risperidone improves negative symptoms in stable psychotic patients

被引：0
|
作者：
Curtis, V. A.
Katsafouros, K.
Moeller, H. J.
Medori, R.
Sacchetti, E.
机构：
[1] Maudsley Hosp & Inst Psychiat, Inst Psychiat, London SE5 8AZ, England
[2] Dromokait State Hosp, Psychotherapeut Ctr, Tarsi Psychiat Clin, Athens, Greece
[3] Univ Munich, Dept Psychiat, D-8000 Munich, Germany
[4] Med Affairs EMEA, Beerse, Belgium
[5] Univ Brescia, Sch Med, Univ Psychiat Unit, Brescia, Italy
[6] Brescia Spedali Civili, Dept Mental Hlth, Brescia, Italy
来源：
EUROPEAN PSYCHIATRY | 2007年 / 22卷
关键词：
D O I：
10.1016/j.eurpsy.2007.01.487
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [41] Effectiveness of long-acting risperidone for patients with treatment refractory schizophrenia
    Kimura, H.
    Kanahara, N.
    Komasu, N.
    Ishige, M.
    Muneoka, K.
    Yoshimura, M.
    Yamanaka, H.
    Suzuki, T.
    Watanabe, H.
    Sekine, Y.
    Iyo, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 53 - 54
  • [42] Risperidone long-acting injectable in patients with a new diagnosis of psychosis
    Parellada, E
    Chrzanowski, W
    Andrezina, R
    Milanova, V
    Glue, P
    Medori, R
    Masiak, M
    EUROPEAN PSYCHIATRY, 2005, 20 : S75 - S76
  • [43] Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
    Kim, H.
    Hong, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S456 - S456
  • [44] Patients' acceptance of the deltoid application of risperidone long-acting injection
    Heres, Stephan
    Frobose, Teresa
    Hamann, Johannes
    Leucht, Stefan
    Maino, Katja
    Reichhart, Tatjana
    Stiegler, Michaela
    Kissling, Werner
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (12) : 897 - 901
  • [45] Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
    Ciwoniuk, M.
    Godlewska, B. R.
    Olajossy-Hilkesberger, L.
    Olajossy, M.
    Marmurowska-Michalowska, H.
    Limon, J.
    Landowski, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S456 - S457
  • [46] Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia
    Keith, SJ
    Pani, L
    Nick, B
    Emsley, R
    San, L
    Turner, M
    Conley, R
    Scully, P
    Chue, PS
    Lachaux, B
    PSYCHIATRIC SERVICES, 2004, 55 (09) : 997 - 1005
  • [47] Long-acting risperidone in the treatment of institutionalized mentally retarded patients
    Kouniakis, P.
    Tsirogianni, E.
    Baltatzi, M.
    Sidiropoulos, N.
    Hatzitolios, A.
    Giouzepas, J.
    Fokas, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S530 - S531
  • [48] Long-acting risperidone - Experience in more than 600 patients
    Pajonk, FG
    Schreiner, A
    EUROPEAN PSYCHIATRY, 2005, 20 : S77 - S77
  • [49] Long-acting risperidone in the treatment of institutionalized mentally retarded patients
    Kouniakis, P.
    Tsirogianni, E.
    Baltatzi, M.
    Sidiropoulos, N.
    Hatzitolios, A.
    Giouzepas, I.
    Fokas, K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S206 - S207
  • [50] Efficacy and safety of long-acting injectable risperidone in patients with schizophrenia
    Bouhours, P
    Schreiner, A
    Rendall, MR
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 171
12345